posted on 2023-03-30, 23:09authored byMichelle L. Stewart, Pablo Tamayo, Andrew J. Wilson, Stephanie Wang, Yun Min Chang, Jong W. Kim, Dineo Khabele, Alykhan F. Shamji, Stuart L. Schreiber
A, cell viability after treatment with decitabine (AUC, x-axis) was plotted against the doubling time for each cell line (y-axis) as measured over nine days in 384-well plates at each cell line's optimized density. B, cell viability was measured after treatment with decitabine for nine days in four KRAS-mutant pancreatic cell lines. Data are representative of two independent experiments (14 replicates, mean {plus minus} SD). C, cell viability was measured after treatment with decitabine for nine days in KRAS-mutant (purple) or KRAS¬¬¬-wild type colon (gray) cancer cell lines. Data are representative of two independent experiments. Data are representative of two independent experiments (14 replicates, mean {plus minus} SD).